In advance of oral argument in March, hundreds of #pharmaceutical companies & former #FDA ofcls warned #SCOTUS not to second-guess #scientific#experts & said a ruling against FDA would destabilize the #regulatory system & jeopardize investments in #research & #innovation.
Most of the questions from the justices at argument centered on whether the #antiabortion challengers had a #legal right –or #standing – to file. Lawyers defending the drug said the plaintiffs were not directly #harmed.
Nonilex